Publication | Open Access
OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)
86
Citations
0
References
2018
Year
MedicinePathologyCancer TreatmentCancer GeneticsRadiation OncologyOncologyCell BiologyCancer ResearchLung CancerMolecular Oncology
No additional data available for this publication yet. Check back later!